PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2104583
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2104583
Liquid Handling System Market size was valued at US$ 5,113.6 Million in 2025, expanding at a CAGR of 8.1% from 2026 to 2033.
Liquid handling systems are an essential component of modern laboratory technology that automate or assist with the pipetting, transferring, dispensing, and mixing of liquids. From small electronic pipettes to elaborate robotic workstations, there are many different types available in the market. These systems supporting to reduce human error and repetitive strain, increased throughput and reproducibility. Growing investments in pharmaceutical R&D, genomics, precision medicine, and high throughput screening applications drive adoption of sophisticated liquid handling platforms.
Widespread usage of lab automation solutions in drug discovery, molecular diagnostics, and clinical laboratories also propel demand for error free sample preparation while driving higher productivity rates within laboratories. Technological innovations including robotic liquid handling technologies, AI enabled laboratory automation tools, and integration capabilities involving digital laboratory solutions will further catalyse the expansion of the Liquid Handling Systems Market globally.
Liquid Handling System Market- Market Dynamics
Growing Investments in Laboratory Automation and Drug Discovery Drive Liquid Handling System Market Growth
Increasing investments in laboratory automation, drug research, and drug discovery which leads to the growth of the market. The liquid handling system is used in order to increase the precision, repeatability, and efficiency of laboratory processes through automating repetitive processes such as pipetting, dispensing, sample preparation, and reagent delivery. The liquid handling system is widely used in drug discovery, genomics, proteomics, molecular biology, high-throughput screening, and clinical diagnostics, which requires precision and workflow standardization. There is an increasing need for personalized medicine, biological drugs, cell and gene therapy, and advanced molecular diagnosis which makes pharmaceutical and biotechnological companies to use automated liquid handling systems in order to increase productivity without any human error or sample contamination.
The National Institutes of Health (NIH) spent more than US$47 billion per year and provided more than 60,000 research grants and supported more than 300,000 researchers at 2,500+ institutions, which resulted in $92.89 billion of economic activity. The need for high throughput laboratory automation and liquid handling platforms remains strong, with these investments continuing to push for the market growth. In fact, the more these investments are made, the greater the demand for more sophisticated laboratory automation hardware, such as liquid handling systems, in research labs and pharmaceutical development. In addition, the growth of biopharmaceutical production, digitization of many laboratories, and ongoing technology advancements in robotic automation, AI-driven processes and connected laboratory information systems (LIS) are likely to drive the increase in global adoption of liquid handling systems. Therefore, growing research spending and growing automation in the life science laboratories are anticipated to propel the Liquid Handling System Market during the forecast period.
The Global Liquid Handling System Market is segmented on the basis of Type, Product, Application, End Use, and Region.
Automated liquid handling systems hold largest share in terms of Type segmentation as these are widely used in pharmaceutical research, biotechnology, clinical diagnostics, and genomics laboratories. These systems reduce repetitive pipetting, reagent dispensing, sample preparation, and assay setup tasks in the laboratory, reduce human error and cross-contamination, and enhance productivity. The increasing application of high-throughput screening, next-generation sequencing (NGS), and precision medicine has fueled to the rising need for automated liquid handling platforms.
For instance, in January 2025, Tecan Group launched Veya(TM), a new digital liquid handling platform that simplifies laboratory automation easier and facilitates workflow scalability in research and clinical laboratories. It is characterized by automated liquid handling, software integration, real-time monitoring, and workflow optimization through data analysis. This reflects the increasing trend of intelligent laboratory automation and next-generation liquid handling platforms. The launch reflects the increasing demand for integrated laboratory automation solutions, which improve efficiency, reproducibility and throughput. Furthermore, ELHS are still gaining popularity because of their improved accuracy in dispensing, ease to use and their suitability for routine laboratory use.
Drug Discovery is expected to dominate the Liquid Handling System market due to high investments in pharmaceutical and biotechnology research, high number of biologics, cell and gene therapy development and the increasing usage of high throughput screening technologies. Automated liquid handling systems provide automation support for compound screening, assays set up, PCR preparation, reagents and sample distribution. It enables laboratories to achieve higher levels of throughput and reproducibility while eliminating possible human errors and making research processes faster. The Pharmaceutical Research and Manufacturers of America (PhRMA) reports that the companies belonging to it invested in excess of US$850 billion in the last 10 years in research and development of new medicines and therapies.
The biopharmaceutical industry is also a sector of high expenditure in research and development in the U.S., spending about six times more on research and development per person than any other manufacturing sector. The amount of investment in drug discovery and in development of biological products is prompting the use of advanced automated liquid handling systems that enable greater efficiency in the laboratory, contribute to high throughput screening programs and speed the development of new and unique therapeutics. In addition, the growing use of automated laboratory workflows and molecular diagnostic testing will sustain the Clinical Diagnostics segment's market share, and the growing adoption of precision medicine programs and next-generation sequencing (NGS) technologies will drive the robust growth of the Cancer and Genomics Research segment.
Liquid Handling System Market- Geographical Insights
North America holds largest share in the liquid handling systems as there are some well-developed infrastructure facilities, well-developed pharmaceutical and biotechnological industry and high level of laboratory automation technologies developed in the area. There is a significant increase in the demand for automated liquid handling systems as they are used in research laboratories, pharmaceutical companies and in clinical laboratories due to the large number of genomics, precision medicine and drug discovery projects. For instance, the U.S. National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) utilizes automated robotic liquid handling systems in HTS facility to screen hundreds of thousands of chemical compounds both separately and in combination with each other as possible drug candidates. The systems automate all sample handling operations, allowing for fast, accurate, and repeatable sample processing and enhancing screening throughput, while minimizing human error and reinforcing North America's position in the global market for liquid handling automation, an essential tool in pharmaceutical research.
Europe is also among the significant regions which are going to contribute in the growth of the Liquid Handling System Market, considering that Europe has developed a life science ecosystem, strong pharmaceutical and biotech industries, and increasing adoption rates of laboratory automation systems. It is expected that the demand for advanced liquid handling systems will grow in research institutions and clinical laboratories because of the investments in genomics, precision medicine, and next-generation sequencing (NGS) expected to be carried out in the region in the near future. For example, SPT Labtech has worked with EMBL GeneCore to add SPT Labtech's firefly(R)+ liquid handling platform to next-generation sequencing (NGS) workflows. The partnership simplified library preparation for both low-input and metagenomic sample types, streamlined workflow, increased the reproducibility of the process, and allowed for scalable genomic research. These partnerships between laboratory automation vendors and top European research centres are driving the uptake of automated liquid handling solutions and helping to drive progress in genomics, drug discovery and biomedical research in Europe.
Liquid Handling System market is marked by high competition where leading participants strive hard to innovate, automate laboratories, make strategic alliances and establish a geographical presence. Automation of the liquid handling process, AI-enabled lab systems and work flow automation technologies are striving hard to enhance efficiency of laboratories and are being developed by prominent companies including Thermo Fisher Scientific Inc., Tecan Group Ltd., Hamilton Company, Beckman Coulter Life Sciences (Danaher Corporation), Agilent Technologies, Eppendorf SE, Sartorius AG, Gilson Incorporated, SPT Labtech, Revvity (PerkinElmer), Opentrons Labworks Inc. and Analytik Jena GmbH. In addition, companies are expanding their product portfolios, and they are working with research institutions and pharmaceutical companies to meet the high demand for applications like high throughput screening, precision medicine and next-generation sequencing, which is driving competition in the global Liquid Handling System Market.
In May 2026, At SLAS Europe 2026, Hamilton Company and Cerillo announced a strategic partnership by sharing their expertise in liquid handling and laboratory automation with Cerillo's microplate reader technology. The collaboration was to offer integrated detection and analysis solutions for life science laboratories for microbiome research, synthetic biology, environmental microbiology and high throughput screening applications.
In January 2025, Opentrons Labworks launched the Opentrons Flex High-Throughput NGS Workstation, an automated benchtop solution for hands-free NGS library preparation. The system could accommodate up to 96 samples and include magnetic bead clean-up, thermocycling, and pipetting functions, allowing for streamlined workflow in conjunction with whole genome, long-read, and single-cell sequencing applications.